GLADEL - Grupo Latino Americano de Estudio de Lupus
INSTITUTIONAL

INSTITUTIONAL

GLADEL, Latin American Group for the Study of Lupus

GLADEL is a Latin American initiative, launched and spearheaded by local rheumatologists in 1997 with the purpose of:

  1. Undertaking multi-center studies in local patients with systemic lupus erythematosus (SLE).
  2. Stimulating projects to increase the knowledge of SLE and its consequences in patients, physicians and the community in Latin America.

 

GLADEL is an international group formed by experts in the field of SLE, including more than 50 rheumatology research centers located in main cities from more than 12  Latin American countries. 

 

The group's philosophy is inclusive, enthusiastic and looking forward to the incorporation of new centers and countries within Latin America, as new projects arise linked to the above-mentioned objectives. Decisions are always taken by consensus among equals.

 

GLADEL began its first research protocol with the initiation of the SLE inception cohort in 1997 incorporating to date more than 1400 patients.

 

GLADEL became the PANLAR Study group for Lupus as from 2002 (Presidency of Dr. Antonio Reginato)

Highlighted Contents

Publications

Publications

More than 80 publications in peer reviewed journals.

Learn more
BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS

BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS

A novel study launched by the nextgen of investigators.

Learn more
Education for physicians

Education for physicians

A new educational program about lupus

Learn more
Let's talk about Lupus

Let's talk about Lupus

Topics and frequently asked questions selected by patients.

Learn more